Esposito Francesco, De Martino Marco, D'Angelo Daniela, Mussnich Paula, Raverot Gerald, Jaffrain-Rea Marie-Lise, Fraggetta Filippo, Trouillas Jacqueline, Fusco Alfredo
a Istituto di Endocrinologia ed Oncologia Sperimentale del CNR c/o Dipartimento di Medicina Molecolare e Biotecnologie Mediche; Scuola di Medicina e Chirurgia di Napoli; Università degli Studi di Napoli "Federico II" , Naples , Italy.
Cell Cycle. 2015;14(9):1471-5. doi: 10.1080/15384101.2015.1021520.
Numerous studies have established that High Mobility Group A (HMGA) proteins play a pivotal role on the onset of human pituitary tumors. They are overexpressed in pituitary tumors, and, consistently, transgenic mice overexpressing either the Hmga1 or the Hmga2 gene develop pituitary tumors. In contrast with HMGA2, HMGA1 overexpression is not related to any rearrangement or amplification of the HMGA1 locus in these tumors. We have recently identified 2 HMGA1 pseudogenes, HMGA1P6 and HMGA1P7, acting as competitive endogenous RNA decoys for HMGA1 and other cancer related genes. Here, we show that HMGA1 pseudogene expression significantly correlates with HMGA1 mRNA levels in growth hormone and nonfunctioning pituitary adenomas likely inhibiting the repression of HMGA1 through microRNAs action. According to our functional studies, these HMGA1 pseudogenes enhance the proliferation and migration of the mouse pituitary tumor cell line, at least in part, through their upregulation. Our results point out that the overexpression of HMGA1P6 and HMGA1P7 could contribute to increase HMGA1 levels in human pituitary tumors, and then to pituitary tumorigenesis.
大量研究证实,高迁移率族蛋白A(HMGA)在人类垂体肿瘤的发生过程中起关键作用。它们在垂体肿瘤中过度表达,同样,过表达Hmga1或Hmga2基因的转基因小鼠会发生垂体肿瘤。与HMGA2不同,在这些肿瘤中,HMGA1的过表达与HMGA1基因座的任何重排或扩增均无关。我们最近鉴定出2个HMGA1假基因,即HMGA1P6和HMGA1P7,它们作为HMGA1和其他癌症相关基因的竞争性内源性RNA诱饵。在此,我们表明,在生长激素和无功能垂体腺瘤中,HMGA1假基因表达与HMGA1 mRNA水平显著相关,可能通过微小RNA的作用抑制HMGA1的抑制作用。根据我们的功能研究,这些HMGA1假基因至少部分通过上调来增强小鼠垂体肿瘤细胞系的增殖和迁移。我们的结果指出,HMGA1P6和HMGA1P7的过表达可能有助于提高人类垂体肿瘤中HMGA1的水平,进而促进垂体肿瘤的发生。